It was found to be associatedwith the development and progression of pancreatic cancer.19 For that reason, blocking the Hh pathway wasconsidered by using convenient inhibitors targeting the G proteincoupled receptor Smoothened (SMO), a therapeutic target for the treatmentof pancreatic cancer. Here, SMO is linked to familial pancreatic carcinoma.